Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD of ATOSSA THERAPEUTICS, INC. from Q3 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
ATOSSA THERAPEUTICS, INC. quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and change rate from Q3 2021 to Q3 2023.
  • ATOSSA THERAPEUTICS, INC. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending 30 Sep 2023 was -$6.23M, a 22.8% increase year-over-year.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Change (%)

ATOSSA THERAPEUTICS, INC. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$6.23M +$1.84M +22.8% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2023
Q3 2022 -$8.07M -$2.87M -55.2% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q3 2021 -$5.2M 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.